← Leaderboards
Masood A Shammas
Wayne State University
$1,736,684
Attributed
$1,736,684
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $362.3K · FY2008–12$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$1,736,684 · 1
By mechanism
R01$1,736,684 · 1
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- Asfar S Azmi$3,644,683
- Mark R Spaller$3,532,943
- Kay-Uwe Wagner$7,933,901
- Jill S Barnholtz-Sloan$4,033,431
- Michele L. Cote$4,016,446
Others in their field
Top investigators on “Adenocarcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$39,462,948
- Anirban Maitra · Johns Hopkins University$30,605,004
- Richard M Peek · Vanderbilt University Medical Center$23,246,493
- Gloria M. Petersen · Johns Hopkins University$21,134,227
- Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr$19,098,764
- Dean E. Brenner · University Of Michigan At Ann Arbor$18,393,816
Research focus
AdenocarcinomaAbnormal CellApoptosisBarrett&AposBarrett EsophagusAdenocarcinoma CellBehaviorBiologicalCancer CellCancer Cell GrowthCancer Cell LineCancer PreventionBaseCarcinogenesisCell GrowthCell LineCellsCell SurvivalCharacteristicsChromosomesColumnar MetaplasiaDna DamageDna RepairDna Sequence Rearrangement
Grant awards (5)
Telomerase And Homologous Recombination As Targets In Barrett's Adenocarcinoma$352,013
R01 · FY2012 · CA · contact PI
Telomerase And Homologous Recombination As Targets In Barrett's Adenocarcinoma$352,013
R01 · FY2011 · CA · contact PI
Telomerase And Homologous Recombination As Targets In Barrett's Adenocarcinoma$362,259
R01 · FY2010 · CA · contact PI
Telomerase And Homologous Recombination As Targets In Barrett's Adenocarcinoma$358,111
R01 · FY2009 · CA · contact PI
Telomerase And Homologous Recombination As Targets In Barrett's Adenocarcinoma$312,288
R01 · FY2008 · CA · contact PI